Dr Reddy’s CEO Sees Strength Through Diversity
Erez Israeli Explains The Indian Giant’s ‘Two-Horizon’ Approach To Its Business
With Dr Reddy’s organization now spanning a range of innovative interests and CDMO activities as well as the firm’s traditional small-molecule generics and burgeoning biosimilars businesses, CEO Erez Israeli talked to Generics Bulletin about how these various areas were complementary thanks to the Indian giant’s ‘two-horizon’ approach.
